Article Data

  • Views 282
  • Dowloads 130

Original Research

Open Access

Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition

  • C. Zhao1
  • J. L. Wang1
  • J. Wang1
  • L. J. Zhao1
  • L. H. Wei1,*,

1Department Obstetrics and Gynaecology, Peking University, People’s Hospital, Beijing (R. China)

DOI: 10.12892/ejgo340203 Vol.34,Issue 2,March 2013 pp.124-127

Published: 24 March 2013

*Corresponding Author(s): L. H. Wei E-mail:


Purpose: To investigate the potential risk factors related to the recurrence of cervical cancer following ovarian transposition. Materials and Methods: A total of 105 patients with cervical carcinoma were retrospectively analyzed. Each patient underwent surgical therapy in combination with ovarian transposition from September 2000 to November 2009. The potential risk factors for recurrence following ovarian transposition were analyzed. Results: The average age of the 105 patients was 38.7 years. Twelve patients were in Stage IA, 65 in IB, 12 in Stage IIA, and 16 in Stage IIB. Twenty-five patients had well-differentiated cancer (G1). Fortyeight patients had moderately-differentiated cancer (G2), and 32 patients had poorly-differentiated cancer (G3). Ninety-seven cases were squamous cell carcinoma, three were adenocarcinoma, four were small cell carcinoma, and one case was adenosquamous carcinoma. Five patients (4.8%) had a recurrence, two of whom (1.9%) had ovarian metastasis. Univariate analysis showed that the pathological type (p = 0.005) and degree of differentiation (p = 0.001) were potential risk factors for recurrence of cervical carcinoma following ovarian transposition. Cancer embolus in vessels or lymphatic metastasis was observed in four of the five patients who suffered a recurrence. Conclusion: Pathological type, differentiated degree, and cancer embolus in vessels or lymphatic metastasis were identified as potential risk factors for the recurrence of cervical carcinoma after ovarian transposition.


Cervical carcinoma; Ovarian transposition; Recurrence.

Cite and Share

C. Zhao,J. L. Wang,J. Wang,L. J. Zhao,L. H. Wei. Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition. European Journal of Gynaecological Oncology. 2013. 34(2);124-127.


[1] Parkin D.M.: “The global health burden of infection – associated cancers in the year 2002”. Int. J. Cancer, 2006, 118, 3030.

[2] Wei Lihui: “Study on preservation of female function in therapy of cervical carcinoma”. Chin. J. Obstet. Gynecol., 2005, 40, 217.

[3] Chen Baohuan, Yan Qian, Lin Shuang, Wang Yajun, Fang Shilan. Protection of transposed ovary on ovarian function of patients with cervical carcinoma treated with radiotherapy. Chin. J. Clin. (Electronic Version), 2009, 3, 309.

[4] Pahisa J., Martínez-Román S., Martínez-Zamora M.A., Torné A., Caparrós X., Sanjuán A., Lejárcegui J.A.: “Laparoscopic ovarian transposition in patients with early cervical cancer”. Int. J. Gynecol. Cancer, 2008, 18, 584.

[5] Wang Jianliu, Zhang Xiaohong, Liang Xudong, Wang Shijun, Xing Huimei, Wei Lihui. Evaluation of transposed ovarian function in young women with cervical carcinoma. Chin. J. Obstet. Gynecol., 2006, 41, 229.

[6] Shimada M., Kigawa J., Nishimura R., Yamaguchi S., Kuzuya K., Nakanishi T. et al.: “Ovarian metastasis in carcinoma of the uterine cervix”. Gynecol. Oncol., 2006, 101, 234.

[7] Nakanishi T., Wakai K., Ishikawa H., Nawa A., Suzuki Y., Nakamura S., Kuzuya K.: “A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix”. Gynecol. Oncol., 2001, 82, 504.

[8] L'ubusk M., Kudela M., L'ubusk D., Machac S., Procházka M., Mícková I.: “The effectiveness and complications of ovarian transposition in young women with cervical carcinoma”. Ceska Gynekol., 2004, 69, 283.

[9] Morice P., Haie Meder C., Pautier P., Lhomme C., Castaigne D.: “Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix:report of two cases and surgical implications”. Gynecol. Oncol., 2001, 83, 605.

[10] Ishii K., Aoki Y., Takakuwa K., Tanaka K.: “Ovarian function after radical hysterectomy with ovarian reservation for cervical carcinoma”. J. Reprod. Med., 2001, 46, 347.

[11] Ling Yan, Li Shitong, Song Juan: “Clinical study on ovarian function in patients with cervical carcinoma receiving ovarian transposition”. Proc. Obstet. Gynecol., 2009, 18, 541.

[12] Delotte J., Ferron G., Kuei T.L., Mery E., Gladieff L., Querleu D.: “Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for Stage IB1 adenocarcinoma of the cervix”. J. Minim. Invasive Gynecol., 2009, 16, 106.

[13] Shigematsu T., Ohishi Y., Fujita T., Higashihara J., Irie T., Hayashi T.: “Metastatic carcinoma in a transposed ovary after radical hysterectomy for a Stage 1B cervical adenosquamous cell carcinoma. Case report”. Eur. J. Gynaecol. Oncol., 2000, 21, 383.

[14] Ivanov S., Zervoudis S., Ivanov S.: “Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a Stage I B and II A cervical carcinoma”. Akush. Ginekol. (Sofiia) 2003, 42, 22.

[15] Yamamoto R., Okamoto K., Yukiharu T., Kaneuchi M., Negishi H., Sakuragi N., Fujimoto S.: “A study of risk factors for ovarian metastases in Stage Ib-IIb cervical carcinoma and analysis of ovarian function after a transposition”. Gynecol. Oncol., 2001, 82, 312.

[16] Zhang Meiqing, Chen Mingzhi: “Analysis of 174 cases with cervical carcinoma in women under 35 years old”. Chin. J. Obstet. Gynecol., 2003, 38, 689.

[17] Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadducci A. et al.: “Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)”. Int. J. Gynecol. Cancer, 2007, 17, 623.

[18] Huang K.G., Lee C.L., Tsai C.S., Han C.M., Hwang L.L.: “A new approach for laparoscopic ovarian transposition before pelvic irradiation”. Gynecol. Oncol., 2007, 105, 234.

[19] Plante M., Renaud M.C., François H., Roy M.: “Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature”. Gynecol. Oncol., 2004, 94, 614.

[20] Sanjuán A., Martínez Román S., Martínez-Zamora M.A., Pahisa J.: “Bilateral ovarian metastasis on transposed ovaries from cervical carcinoma”. Int. J. Gynaecol. Obstet., 2007, 99, 64.

[21] Li Ziting, Zhang Zhiyi. Progress and management strategies of cervical carcinoma. Continuing Med. Educ., 2005, 19, 46.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time